I-Daclatasvir Dihydrochloride Intermediate CAS 1007882-23-6 Ubumsulwa >98.0% (HPLC)

Incazelo emfushane:

I-Daclatasvir Dihydrochloride Intermediate Ⅱ

Omqondofana: Daclatasvir T-Butyl Ester

I-CAS: 1007882-23-6

Ubumsulwa: >98.0% (HPLC)

Ukubukeka: Impushana Ephuzi Ngokukhanyayo ukuya Ephuzi

Okumaphakathi kwe-Daclatasvir Dihydrochloride CAS 1009119-65-6

Thintana: UDkt. Alvin Huang

Iselula/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

I-Shanghai Ruifu Chemical Co., Ltd. ingumkhiqizi ohamba phambili we-Daclatasvir Dihydrochloride Intermediate (CAS: 1007882-23-6) enekhwalithi ephezulu.I-Ruifu Chemical ingahlinzeka ngokulethwa komhlaba wonke, amanani ancintisanayo, amanani amancane nayinqwaba atholakalayo.Thenga i-Daclatasvir Dihydrochloride Intermediates,Please contact: alvin@ruifuchem.com

Chemical Properties:

Igama Lekhemikhali I-Di-tert-Butyl (2S,2'S)-2,2'-(4,4'-Biphenyldiylbis(1H-imidazole-5,2-diyl))di(1-Pyrrolidinecarboxylate)
Omqondofana I-Daclatasvir Intermediate Ⅱ;I-Dacaltasvir Ephakathi 02;I-Daclatasvir T-Butyl Ester;I-Bis(2-Methyl-2-Propanyl) (2S,2'S)-2,2'-[4,4'-Biphenyldiylbis(1H-Imidazole-4,2-diyl)]di(1-Pyrrolidinecarboxylate);I-Di-tert-butyl 2,2′-([1,1′-Biphenyl]-4,4′-diylbis(1H-Imidazole-5,2-diyl))(2S,2'S)-bis(Pyridineidine-1- I-Carboxylate);(2S,2'S)-2,2'-([1,1'-Biphenyl]-4,4'-diyldi-1H-Imidazole-5,2-diyl)bis-1-Pyrrolidinecarboxylic Acid 1,1'-Bis (1,1-Dimethylethyl) Ester;I-Daclatasvir Ukungcola 4
Isimo Sesitoko Ku-Stock, Commercial Production
Inombolo ye-CAS 1007882-23-6
I-Molecular Formula I-C40H51ClN8O6
Isisindo samangqamuzana 775.35 g/mol
Iphuzu elibilayo 890.2±65.0℃ ku-760 mmHg
Ukuminyana 1.220±0.06 g/cm3
I-COA ne-MSDS Iyatholakala
Umsuka Shanghai, China
Isigaba Okumaphakathi kwe-Daclatasvir Dihydrochloride (CAS: 1009119-65-6)
Ibhrendi I-Ruifu Chemical

Imininingwane:

Izinto Imininingwane Imiphumela
Ukubukeka Impushana Ephuzi Ekhanyayo ukuya Ephuzi
Impushana Ephuzi Ekhanyayo
Ukulahlekelwa Ekumisweni <1.00% 0.65%
Ukungcola Okukodwa Okukhulu <1.00% 0.45%
Ukungcola Okuphelele <2.00% 1.24%
Ukuhlanzeka / Indlela Yokuhlaziya >98.0% (HPLC) 98.76%
I-Infrared Spectrum Ihambisana Nesakhiwo Iyahambisana
1H NMR Spectrum Ihambisana Nesakhiwo Iyahambisana
Isiphetho Umkhiqizo uhloliwe futhi uthobela imininingwane enikeziwe
Isicelo Okumaphakathi kwe-Daclatasvir Dihydrochloride (CAS: 1009119-65-6)

Iphakheji/Isitoreji/Ukuthumela ngomkhumbi:

Iphakheji:Ibhodlela eliFluorinated, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwezidingo zekhasimende.
Isimo Sesitoreji:Gcina isitsha sivalwe ngokuqinile futhi usigcine endaweni epholile, eyomile futhi enomoya omuhle kude nezinto ezingahambelani.Vikela ekukhanyeni nakumswakama.
Ukuthumela:Zilethe emhlabeni wonke ngendiza, yi-FedEx/DHL Express.Nikeza ukulethwa okusheshayo nokuthembekile.

Izinzuzo:

Amandla Anele: Izinsiza ezanele kanye nochwepheshe

Isevisi Yobuchwepheshe: Isevisi yokuthenga yokuma eyodwa

Iphakheji le-OEM: Iphakheji yangokwezifiso kanye nelebula iyatholakala

Ukulethwa Okusheshayo: Uma kungaphakathi kwesitoko, ukulethwa kwezinsuku ezintathu kuqinisekisiwe

Impahla Ezinzile: Gcina isitoko esinengqondo

Ukusekelwa Kwezobuchwepheshe: Isixazululo sezobuchwepheshe siyatholakala

Isevisi Yokuhlanganisa Ngokwezifiso: Isukela kumagremu kuye kumakhilo

Ikhwalithi Ephezulu: Kusungulwe uhlelo oluphelele lokuqinisekisa ikhwalithi

I-FAQ:

Indlela Yokuthenga?Sicela uxhumaneDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com 

Iminyaka engu-15 Yokuhlangenwe nakho?Sinesipiliyoni seminyaka engaphezu kwe-15 ekwakhiweni nasekuthumeleni kwamanye amazwe uhla olubanzi lwezinga eliphezulu lokuxhumanisa imithi noma amakhemikhali amahle.

Izimakethe Eziyinhloko?Thengisa emakethe yasekhaya, eNyakatho Melika, eYurophu, eNdiya, eKorea, eJapane, e-Australia, njll.

Izinzuzo?Ikhwalithi ephezulu, intengo ethengekayo, izinsizakalo ezichwepheshile nokusekelwa kobuchwepheshe, ukulethwa okusheshayo.

IkhwalithiIsiqiniseko?Isistimu yokulawula ikhwalithi eqinile.Imishini yobuchwepheshe yokuhlaziya ifaka i-NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, NOMA, KF, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, njll.

Amasampula?Imikhiqizo eminingi inikeza amasampula wamahhala wokuhlolwa kwekhwalithi, izindleko zokuthumela kufanele zikhokhelwe amakhasimende.

Ukuhlolwa Kwemboni?Wamukelekile ekucwaningweni kwemboni.Sicela wenze i-aphoyintimenti kusengaphambili.

I-MOQ?Ayikho i-MOQ.I-oda elincane liyamukeleka.

Isikhathi sokuthumela? Uma kungaphakathi kwesitoko, ukulethwa kwezinsuku ezintathu kuqinisekisiwe.

Ezokuthutha?By Express (FedEx, DHL), by Air, by Sea.

Amadokhumenti?Ngemuva kwenkonzo yokuthengisa: I-COA, i-MOA, i-ROS, i-MSDS, njll.

Custom Synthesis?Ingahlinzeka ngezinsizakalo zokwenziwa ngokwezifiso ukuze zilingane kangcono nezidingo zakho zocwaningo.

Imigomo Yokukhokha?I-invoyisi ye-Proforma izothunyelwa kuqala ngemva kokuqinisekiswa kwe-oda, kufakwe nemininingwane yethu yasebhange.Inkokhelo nge-T/T (Telex Transfer), PayPal, Western Union, njll.

Isicelo:

I-Di-tert-Butyl (2S,2'S)-2,2'-(4,4'-Biphenyldiylbis(1H-imidazole-5,2-diyl))di(1-Pyrrolidinecarboxylate) (CAS: 1007882-23-6) iphakathi kwe-Daclatasvir Dihydrochloride (CAS: 1009119-65-6).
I-Daclatasvir (i-Daklinza) ithole isimo "sokubuyekezwa okubalulekile", okuhlanganiswe ne-Sorafenib yokwelapha iziguli ezikhulile ze-genotype III ezine-hepatitis C engapheli. ukutheleleka ngaphandle kokuphatha ngokubambisana ne-interferon noma i-ribavirin.I-Interferon ne-Ribavirin yimithi emibili egunyazwe yi-FDA yokwelapha ukutheleleka ngegciwane le-hepatitis C.I-Hepatitis C yisifo segciwane esingabangela ukuvuvukala kwesibindi, okuholela ekunciphiseni ukusebenza kwesibindi noma ukwehluleka kwesibindi.Iziguli eziningi ezingenwe isifo sokusha kwesibindi kohlobo C azinazo izimpawu kuze kube yilapho kubonakala ukulimala kwesibindi, okungase kuthathe iminyaka eminingana.Emhlabeni jikelele, i-genotype III i-hepatitis C iwuhlobo lwesibili oluvame kakhulu lwesifo sokusha kwesibindi kohlobo C ngemuva kwe-genotype 1 ye-hepatitis C futhi sithathwa njengesinye sezifo ze-genotype eziphika kakhulu.I-Daklinza iyi-pan-genotype NS5A replication complex inhibitor, esebenza ngempumelelo ekuvimbeleni ukuphindaphinda kwe-RNA nokuhlangana kwegciwane, umphumela we-antiviral okabili.Ezifundweni ze-in vitro, i-Daklinza iboniswe ukuthi inomphumela wokulwa negciwane ngokumelene ne-genotype 1 ~ 6 igciwane le-hepatitis C.I-Daklinza ihambisana nesexwayiso sokuthi inhlanganisela ye-amiodarone, i-Daklinza ne-Sofosbuvir ingase ibangele ukushaya kwenhliziyo okunciphe kakhulu.I-Daklinza ithebhulethi yomlomo enomthamo onconyiwe ongu-60 mg izikhathi ezi-1/d, ngokuhlangana ne-Sofosbuvir ingqikithi yamasonto ayi-12.
Inkampani yocwaningo nentuthuko: Bristol-Myers Squibb.
I-Patent Literature: WO 2008021927A2 (August 9, 2007).
Isikhathi sokumaketha: Julayi 24, 2015 esohlwini lwase-United States, igama lokuhweba Daklinza.
Izinkomba: Isetshenziswa lihambisana Sofosbuvir ekwelapheni genotype 3 chronic hepatitis C (HCV) ukutheleleka.
Indlela yokwenza: i-HCV nonstructural protein 5A (NS5A) inhibitors.Ukusabela Okubi: ubuhlungu bekhanda nokukhathala.
Ukwakhiwa kanye nokucaciswa: Amaphilisi, 30 kanye 60mg.

Bhala umyalezo wakho lapha futhi usithumelele wona